eli lilly glp-1 advantage decreasing A Big Week for Drugs - by Eric Topol Eli Lilly's New $299 Month-Long

Balette says can easily get lost in the broader cultural conversation about these drugs

Clinical Evidence for Semaglutide-Naltrexone Combination The strongest evidence for semaglutide plus naltrexone comes from the IMCOSI phase 2b trial (2021), which enrolled 338 patients and found that the combination resulted in approximately 20% body weight loss over 48 weeks, compared to 16% for semaglutide alonea difference that was statistically significant but modest in absolute terms

Instead, drink most of your fluids between meals for better absorption and comfort

While most GLP-1 drugs are currently available as injections, the introduction of new oral formulations, which could be easier for patients to take, could result in additional shifts in utilization among GLP-1s

Chuang et al